Neobe Overview
- Year Founded
-
2021

- Status
-
Private
- Employees
-
10

- Latest Deal Type
-
Seed
- Latest Deal Amount
-
$2.36M
- Investors
-
14
Neobe General Information
Description
Developer of a synthetic biology platform designed to promote therapeutic efficacy in patients with solid tumors. The company's platform creates a programmable bacteria that alters the microenvironment of solid tumors from within by locally breaking down stromal barriers which increases immune cell and drug infiltration and helps to avoid systemic toxicities while increasing efficacy, enabling patients to respond to immunotherapies.
Contact Information
Website
www.neobetherapeutics.comCorporate Office
- Salisbury House
- Station Road
- Cambridge CB1 2LA
- England, United Kingdom
Corporate Office
- Salisbury House
- Station Road
- Cambridge CB1 2LA
- England, United Kingdom
Neobe Timeline
Neobe Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
10. Seed Round | 22-Dec-2023 | $2.36M | Completed | Pre-Clinical Trials | ||
9. Accelerator/Incubator | Completed | Pre-Clinical Trials | ||||
8. Accelerator/Incubator | Completed | Pre-Clinical Trials | ||||
7. Grant | Completed | Pre-Clinical Trials | ||||
6. Accelerator/Incubator | 14-Jun-2023 | Completed | Product In Beta Test | |||
5. Seed Round | 23-Nov-2022 | Completed | Product In Beta Test | |||
4. Grant | 01-May-2022 | Completed | Product In Beta Test | |||
3. Accelerator/Incubator | 28-Sep-2021 | Completed | Product In Beta Test | |||
2. Seed Round | 12-Mar-2021 | $195K | $195K | Completed | Generating Revenue | |
1. Accelerator/Incubator | 20-Jan-2021 | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Neobe Patents
Neobe Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
GB-202311258-D0 | Methods and compostions | Pending | 21-Jul-2023 |
Neobe Signals
Neobe Investors (14)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
2048 Ventures | Venture Capital | Minority | ||
Pioneer Group (London) | Venture Capital | Minority | ||
Creative Destruction Lab | Accelerator/Incubator | |||
Discovery Park Ventures | Family Office | Minority | ||
Angel (individual) | Minority |
Neobe FAQs
-
When was Neobe founded?
Neobe was founded in 2021.
-
Where is Neobe headquartered?
Neobe is headquartered in Cambridge, United Kingdom.
-
What is the size of Neobe?
Neobe has 10 total employees.
-
What industry is Neobe in?
Neobe’s primary industry is Biotechnology.
-
Is Neobe a private or public company?
Neobe is a Private company.
-
What is Neobe’s current revenue?
The current revenue for Neobe is
. -
How much funding has Neobe raised over time?
Neobe has raised $2.86M.
-
Who are Neobe’s investors?
2048 Ventures, Pioneer Group (London), Creative Destruction Lab, Discovery Park Ventures, and are 5 of 14 investors who have invested in Neobe.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »